Although diabetic kidney disease (DKD) remains the leading cause of end-stage kidney disease eventually requiring chronic kidney replacement therapy, the prevalence of DKD has failed to decline over the past 30 years. In order to reduce disease prevalence, extensive research has been ongoing to improve prediction of DKD onset and progression. Although the most commonly used markers of DKD are albuminuria and estimated glomerular filtration rate, their limitations have encouraged researchers to search for novel biomarkers that could improve risk stratification. Considering that DKD is a complex disease process that involves several pathophysiologic mechanisms such as hyperglycemia induced inflammation, oxidative stress, tubular damage, eventually leading to kidney damage and fibrosis, many novel biomarkers that capture one specific mechanism of the disease have been developed. Moreover, the increasing use of high-throughput omic approaches to analyze biological samples that include proteomics, metabolomics, and transcriptomics has emerged as a strong tool in biomarker discovery. This review will first describe recent advances in the understanding of the pathophysiology of DKD, and second, describe the current clinical biomarkers for DKD, as well as the current status of multiple potential novel biomarkers with respect to protein biomarkers, proteomics, metabolomics, and transcriptomics.
Citations
Citations to this article as recorded by
β-sitosterol potential against chronic hyperglycemia induced diabetic nephropathy: A dual approach using computational and in-vivo studies Sachin Sharma, Manjusha Choudhary, Jeevan K, Onkar Sharma, Hari Kishan, Ashwani Mittal Journal of Ethnopharmacology.2026; 357: 120934. CrossRef
Duration-dependent alterations of lipid profiles and microvascular complications in GCK-MODY Yadi Huang, Yuxin Fan, Yang Liu, Xuan Liu, Wei Li, Ying Yang, Ziyue Zhang, Shifeng Ma, Shuhui Ji, Shanshan Chen, Hua Shu, Wenli Feng, Kunling Wang, Qing He, Wenjun Qi, Ming Liu, Xin Li, Yu Fan Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2026; 1872(3): 168137. CrossRef
Extracellular vesicles in diabetic kidney disease: Emerging mechanisms, therapeutic implications, and biomarker prospects Yang Yu, Yunjie Shan, Anjie Ding, Hui Qian Biochemical Pharmacology.2026; 244: 117605. CrossRef
S-methylmethionine ameliorates renal injury in diabetic mice by modulating macrophage inflammaging via ERK/NF-κb signaling pathway Hao Dong, Linjie Shen, Pawuziya Abulizi, Yuezhang Sun, Lulingxiao Nie, Aimin Cui, Qian Fu, Ning Ji, Yuwen Luo, Chienshan Chen, Aimin Xu, Wai Keung Leung, Qi Wang International Immunopharmacology.2026; 170: 116038. CrossRef
A non-invasive urinary diagnostic signature for diabetic kidney disease revealed by machine learning and single-cell analysis Yonggang Chen, Jintai Luo, Yingying Zheng, Xiaomei Jiang, Zixiang Yang, Xiaobing Liu, Yusuf Oloruntoyin Ayipo PLOS One.2026; 21(1): e0340096. CrossRef
Emerging technologies for early risk stratification and precision management of diabetic kidney disease: a multimodal framework integrating digital phenotypes and clinical biomarkers Lingdong Meng, Zhen Li, Ling Xu, Fang Wei, Hongyan Ji, Lankun Zhang, Anning Zhu, Zhijia Zhou Frontiers in Endocrinology.2026;[Epub] CrossRef
Glycerol-selective biosensor and microbial biofuel cell based on recombinant yeast and glycerol dehydrogenase nanocomposite Nataliya Stasyuk, Andriy Zakalskiy, Daria Larowska-Zarych, Oksana Zakalska, Susanna Kushnir, Iryna Slyvka, Olha Demkiv, Sylwester Gawinkowski, Marcin Holdynski, Wojciech Nogala, Mykhailo Gonchar Microchemical Journal.2026; 221: 116853. CrossRef
C‐X‐C Motif Chemokine Ligand 3 as a Potential Biomarker for Diagnosis and Prognosis of Diabetic Kidney Disease Sensen Su, Xin Chen, Li Zhang, Hui Yu, Han Qin, Lin Li, Zhanchuan Ma, Yinyu Yu, Zhonggao Xu, Huanfa Yi The FASEB Journal.2026;[Epub] CrossRef
The triglyceride-high-density lipoprotein-glucose-body index: a superior novel biomarker for diabetic kidney disease in type 2 diabetes Jian Yang, Bingsong Xie, Zhiling Deng, Zhifu Zhang, Hairong Zhou Frontiers in Endocrinology.2026;[Epub] CrossRef
Diabetic kidney disease, biomarkers, and finerenone Ashish Verma, Ashish Upadhyay Diabetes, Obesity and Metabolism.2026;[Epub] CrossRef
Functional Molecular Plasma Biomarkers of Inflammation and Repair in Kidney Disease Progression in Gum Arabica Modality of CKD Sameeha AlShelleh, Maysa Suyagh, Hussein Alhawari, Nailya Bulatova, Violet Kasabri, Ayman Wahbeh, Izzat Alawwa, Ashraf Oweis, Haneen Mustafa International Journal of Molecular Sciences.2026; 27(2): 973. CrossRef
N6-methyladenosine in inflammatory diseases: Important actors and regulatory targets Zewen Li, Yongfeng Lao, Rui Yan, Fuhan Li, Xin Guan, Zhilong Dong Gene.2025; 936: 149125. CrossRef
Proteomics exploration of metformin hydrochloride for diabetic kidney disease treatment via the butanoate metabolism pathway Jinxuan Chai, Yan Wang, Sifan Guo, Zhibo Wang, Hongwei Chen, Xian Wang, Dandan Xie, Ying Cai, Shiwei Wang, Zhencai Hu, Aihua Zhang, Shi Qiu Journal of Pharmaceutical and Biomedical Analysis.2025; 254: 116584. CrossRef
Global research hotspots and trends in oxidative stress-related diabetic nephropathy: a bibliometric study Xiao-rong Wang, Zeng Wu, Tong-tong He, Xiao-han Chen, Xiao-fei Jin, Chun-yue Zuo, Shao-ze Yang, Yu Gao, Xiao-hong Zhou, Wei-juan Gao Frontiers in Endocrinology.2025;[Epub] CrossRef
Implementing novel complete blood count-derived inflammatory indices in the diabetic kidney diseases diagnostic models Ali Hassanzadeh, Mehdi Allahdadi, Sepehr Nayebirad, Nazli Namazi, Ensieh Nasli-Esfahani Journal of Diabetes & Metabolic Disorders.2025;[Epub] CrossRef
NR4A1 silencing alleviates high-glucose-stimulated HK-2 cells pyroptosis and fibrosis via hindering NLRP3 activation and PI3K/AKT pathway Jin-Meng Li, Zi-Hua Song, Yuan Li, Han-Wen Chen, Han Li, Lu Yuan, Jing Li, Wen-Yue Lv, Lei Liu, Na Wang World Journal of Diabetes.2025;[Epub] CrossRef
Association between drinking patterns and diabetic kidney disease in United States adults: a cross-sectional study based on data from NHANES 1999–2016 Xusheng Yang Renal Failure.2025;[Epub] CrossRef
Mechanisms, Biomarkers, and Treatment Approaches for Diabetic Kidney Disease: Current Insights and Future Perspectives Jean Paule Joumaa, Angela Raffoul, Charbel Sarkis, Elizabeth Chatrieh, Sally Zaidan, Philippe Attieh, Frederic Harb, Sami Azar, Hilda E. Ghadieh Journal of Clinical Medicine.2025; 14(3): 727. CrossRef
Investigation of the role and mechanism of dapagliflozin in mitigating renal injury in rats afflicted with diabetic kidney disease Hao Wang, Xiuli Zhao, Xiao Wang, Yi Gong, Songping Li, Yanting Gu, Bosai He, Jiahong Wang Biochemical Pharmacology.2025; 233: 116795. CrossRef
Progress in the application of novel inflammatory indicators in chronic kidney disease Wenrui Gao, Xiangyu Wang, Yulin Zou, Sheng Wang, Jun Dou, Senlin Qian Frontiers in Medicine.2025;[Epub] CrossRef
Serum advanced glycation end products as a putative biomarker in Type2 DKD patients’ prognosis Ze-Hou Wang, Zong-Jin Zhang, Yue-Fen Wang, Jin Xie, Yi-Min Li, Cun Shen, Yuan Meng, Wen-Jing Zhao, Lu-Ying Sun, Wei Jing Liu Frontiers in Physiology.2025;[Epub] CrossRef
The Potential of Blood KIM‐1 as a Biomarker in Early Diagnosis of Diabetic Kidney Disease Ningjie Gong, Qian Wang, Zhaoqing Cong, Lezhi Xu, Wenqian Yang, Yang Du iLABMED.2025; 3(1): 29. CrossRef
Detection of Fast Decliner of Diabetic Kidney Disease Using Chiral Amino Acid Profiling: A Pilot Study Yosuke Hirakawa, Tomonori Kimura, Shinsuke Sakai, Masayuki Mizui, Masashi Mita, Yoshitaka Isaka, Masaomi Nangaku, Reiko Inagi Chemistry & Biodiversity.2025;[Epub] CrossRef
Biomarkers: New Advances in Diabetic Nephropathy Yujia Chen, Xinan Liu, Meniga Shengbu, Qian Shi, Suolang Jiaqiu, Xianrong Lai Natural Product Communications.2025;[Epub] CrossRef
Uncovering the mechanism of Huangkui capsule in the treatment of diabetic kidney disease based on network pharmacology and experimental validation Junhong Liu, Ziwei Li, ZongYao Zhang, Zhongyuan Shen Scientific Reports.2025;[Epub] CrossRef
Association of normal range of urinary albumin‐to‐creatinine ratio with all‐cause mortality among diabetic adults with preserved kidney function: National Health and Nutrition Examination Survey (NHANES) 2003–2018 Xiaoxia Pang, Wenchao Dan, Lan Lin, Huimei Li, Xiangrong Rao, Shen Li Diabetes, Obesity and Metabolism.2025; 27(5): 2670. CrossRef
Oxidative protein destruction products as markers of chronic kidney disease progression in diabetes mellitus MV Osikov, LA Efros, LYu Zhuravleva, AA Fedosov Bulletin of Russian State Medical University.2025;[Epub] CrossRef
Research Progress of Factors Influencing Bleeding of Percutaneous Nephrolithotomy 丽梅 王 Advances in Clinical Medicine.2025; 15(03): 1580. CrossRef
Serum metabolic profiling of patients with diabetic kidney disease based on gas chromatography-mass spectrometry Xueyan Bian, Chenwen Wang, Majie Wang, Ailing Yin, Jiayan Xu, Mijia Liu, Hui Wang, Yating Cao, Xin Huang, Chenxue Qin, Ye Zhang, Heming Yu Frontiers in Molecular Biosciences.2025;[Epub] CrossRef
A Machine Learning-Based Prediction Model for Diabetic Kidney Disease in Korean Patients with Type 2 Diabetes Mellitus Kyung Ae Lee, Jong Seung Kim, Yu Ji Kim, In Sun Goak, Heung Yong Jin, Seungyong Park, Hyejin Kang, Tae Sun Park Journal of Clinical Medicine.2025; 14(6): 2065. CrossRef
Association of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in population with cardiovascular-kidney-metabolic syndrome stages 0–4: evidence from a large cohort study Fan-Shun Guo, Jia-Hao Dou, Jun-Xiang Wang, Chen Guo, Rui-Yun Wu, Xue-Lu Sun, Yi-Wei Hu, Jin Wei Diabetology & Metabolic Syndrome.2025;[Epub] CrossRef
Progress and perspectives of metabolic biomarkers in blood sample for diabetic microvascular complications Li Yan, Xu Wang, Yujie Xiang, Shuyi Ru, Cheng Fang, Xiuhong Wu Metabolomics.2025;[Epub] CrossRef
Predicting diabetic kidney disease with serum metabolomics and gut microbiota Yuyun Hu, Xue Ni, Qinghuo Chen, Yihui Qu, Kanan Chen, Gaohui Zhu, Minqiao Zhang, Ningjie Xu, Xu Bai, Jing Wang, Yanhong Ma, Qun Luo, Kedan Cai Scientific Reports.2025;[Epub] CrossRef
Circulating Neutrophil and Monocyte Ratios to High Density Lipoprotein-Cholesterol Are Elevated with Increased Triglyceride-Glucose Index Ishwarlal Jialal, Beverley Adams-Huet International Journal of Clinical and Translational Medicine.2025; : 5. CrossRef
Cardiovascular Risk Reduction in Patients with Type 2 Diabetes: What Does the Cardiologist Need to Know? Martin Berger, Nikolaus Marx, Katharina Marx-Schütt European Cardiology Review.2025;[Epub] CrossRef
Contemporary Perspectives on Chronic Renal Disorders Deenadhayalan Ashok, Poornima Ajay Manjrekar, Bhushan C. Shetty, Sujina S. S, Rukmini Mysore Srikantiah, Sowndarya Kollampare Chronic Diseases and Translational Medicine.2025; 11(2): 89. CrossRef
Baseline comorbidity of cardiovascular-kidney-metabolic syndrome increases the risk of adverse clinical outcomes in patients with chronic kidney disease Jiali Meng, Wen Li, Wenjing Fu, Aihua Zhang Frontiers in Endocrinology.2025;[Epub] CrossRef
Yangonin Attenuates Streptozotocin-induced Diabetic Nephropathy in Rats via Downregulating Oxidative Stress and Inflammatory Responses Zhenzhen Hao, Lin Li, Youlan Gong, Yang Xu Pharmacognosy Magazine.2025; 21(4): 1562. CrossRef
The association between the cardiac metabolic index and rapid kidney function decline and CKD in individuals with different glucose metabolism statuses: results from the China health and retirement longitudinal study Wei-Zhen Tang, Qin-Yu Cai, Tai-Hang Liu, Tao-Ting Li, Gao-hui Zhu, Jia-cheng Li, Kang-Jin Huang, Hong-Yu Xu, He-Zhe Hua, Rong Li Lipids in Health and Disease.2025;[Epub] CrossRef
Systemic immune indicators for predicting renal damage in newly diagnosed type 1 diabetic children Lan-Fang Cao, Qing-Bo Xu, Li Yang World Journal of Diabetes.2025;[Epub] CrossRef
Shenzhuo formulation ameliorates diabetic nephropathy by regulating cytochrome P450-mediated arachidonic acid metabolism Zhong-Yong Zhang, Yu-Ming Wang, Ning Wang, Yuan-Song Wang, Hui Zhang, Duo Wang, Li-Xin Wang, Huan-Tian Cui, Wei-Bo Wen, Shu-Quan Lv, Yong-Jun Cao World Journal of Diabetes.2025;[Epub] CrossRef
An update on renal tubular injury as related to glycolipid metabolism in diabetic kidney disease Anqi Feng, Ruili Yin, Rong Xu, Baoyu Zhang, Longyan Yang Frontiers in Pharmacology.2025;[Epub] CrossRef
Revealing VCAN as a Potential Common Diagnostic Biomarker of Renal Tubules and Glomerulus in Diabetic Kidney Disease Based on Machine Learning, Single-Cell Transcriptome Analysis and Mendelian Randomization Li Jiang, Jie Jian, Xulin Sai, Xiai Wu Diabetes & Metabolism Journal.2025; 49(3): 407. CrossRef
Dynamic DNA methylation of EPHX2 in diabetic kidney disease progression: A potential biomarker Guoxiong Deng, Ziyi Feng, Xiaomu Kong, Peng Gao, Yongwei Jiang, Yi Liu, Meimei Zhao, LiangMa Gene Reports.2025; 40: 102245. CrossRef
Histone deacetylases and their inhibitors in kidney diseases Yue Zheng, Tie-Ning Zhang, Peng-Hui Hao, Ni Yang, Yue Du Molecular Therapy.2025; 33(8): 3485. CrossRef
Spinach Extract Reduces Kidney Damage in Diabetic Rats by Impairing the AGEs/RAGE Axis Javier Flores-Estrada, Agustina Cano-Martínez, Luz Ibarra-Lara, Adriana Jiménez, Carmen Palacios-Reyes, Luis J. Pinto García, María G. Ortiz-López, Olga Nelly Rodríguez-Peña, Luis Barbo Hernández-Portilla International Journal of Molecular Sciences.2025; 26(10): 4730. CrossRef
KIM-1 como biomarcador de lesão tubular renal em pacientes com diabetes mellitus tipo 2 normoalbuminúricos e com resistência à insulina Laura Eduarda de Oliveira, Clóvis Paniz, Rafael Noal Moresco, José Antonio Mainardi de Carvalho Brazilian Journal of Nephrology.2025;[Epub] CrossRef
KIM-1 as a biomarker of kidney tubular damage in normoalbuminuric patients with type 2 diabetes mellitus and insulin resistance Laura Eduarda de Oliveira, Clóvis Paniz, Rafael Noal Moresco, José Antonio Mainardi de Carvalho Brazilian Journal of Nephrology.2025;[Epub] CrossRef
Role of Physical Activity in Reducing Diabetic Kidney Disease Risk in Adults: Data From the National Health and Nutrition Examination Survey, 2017–2018 Wirampa Tanglai, Apichai Wattanapisit, Osamu Watanabe, Thanakrit Jeamjitvibool, Mark Lockwood, Mia Cajita Diabetes/Metabolism Research and Reviews.2025;[Epub] CrossRef
Genetics of diabetes and its complications: a comprehensive review Abdul Sami, Ahsan Javed, Dilber Uzun Ozsahin, Ilker Ozsahin, Khalid Muhammad, Yasir Waheed Diabetology & Metabolic Syndrome.2025;[Epub] CrossRef
Serum metabolic profiling in diabetic kidney disease patients using ultra-high performance liquid chromatography-tandem mass spectrometry Bin Zhang, Chunmei Dai, Jiuyi Jiang, Jun Wang, Yuwei Yang, Jiafu Feng Diabetology & Metabolic Syndrome.2025;[Epub] CrossRef
Urine Biomarkers for Diabetic Kidney Disease Progression in Participants of the Chronic Renal Insufficiency Cohort Study Sarah J. Schrauben, Xiaoming Zhang, Dawei Xie, Steven Coca, Jason H. Greenberg, Joachim H. Ix, Michael G. Shlipak, Chi-yuan Hsu, Jonathan J. Taliercio, Chirag R. Parikh, Orlando Gutierrez, Mark J. Sarnak, Mirela A. Dobre, Debbie Cohen, Jeffrey R. Schellin Clinical Journal of the American Society of Nephrology.2025; 20(7): 958. CrossRef
Melatonin Protects Against Diabetic Kidney Disease via the SIRT1/NLRP3 Signalling Pathway Yaping Zhang, Yinghui Wang, Jingyan Yang, Gang Liu Nephrology.2025;[Epub] CrossRef
Association Between DNA Methylation of MTHFR and Diabetic Kidney Disease Guoxiong Deng, Ziyi Feng, Xiaomu Kong, Peng Gao, Yongwei Jiang, Yi Liu, Meimei Zhao, Liang Ma, Kalyani Sen Journal of Diabetes Research.2025;[Epub] CrossRef
PHGDH alleviates DKD by regulating YB1/SLC7A11-mediated ferroptosis in podocytes Yinghui Wang, Qingqing Zhang, Shasha Lv, Xueling Wang, Qingzhen Liu, Xiangchun Liu, Yaping Zhang, Gang Liu Translational Research.2025; 282: 1. CrossRef
Comparative effectiveness of traditional Chinese medicine injections combined with ACEI/ARB for diabetic nephropathy: A systematic review and network meta-analysis Aijing Li, Maoying Wei, Chan Wu, Dan Yin, Yiting Tang, Yijia Jiang, Churan Wang, Jingyi Guo, Anning Sun, Xin Gu, Yanbing Gong Frontiers in Pharmacology.2025;[Epub] CrossRef
Fecal microbiota transplantation is a promising therapy for kidney diseases Jiawei Zhang, Xiangge Ren, Bing Li, Zhifen Zhao, Shoudao Li, Wensheng Zhai Frontiers in Medicine.2025;[Epub] CrossRef
Kaempferol improves mitochondrial homeostasis via mitochondrial dynamics and mitophagy in diabetic kidney disease Chenhui Xia, Jiale Zhang, Huixi Chen, Weimin Jiang, Shaofeng Zhou, Huijuan Zheng, Weiwei Sun International Immunopharmacology.2025; 162: 115121. CrossRef
Polygonati Rhizoma Polysaccharides Ameliorated Diabetic Kidney Disease in db/db Mice via Inhibiting TGFβ/Smad2 Signaling Pathway Xiyu Mei, Zeming Ren, Ziyun Gao, Sisi Chen, Xuan Chen, Qingyun Zhou, Yeling Tong, Guanhai Dai Food Science & Nutrition.2025;[Epub] CrossRef
Therapeutic Potential of Cinnamic Acid as an SGLT2 Inhibitor in Mitigating Diabetic Nephropathy in a Rat Model of Type 2 Diabetes Setah Naif Alotaibi, Ghedeir M. Alshammari, Nawal A. Albadr, Mohammed Abdo Yahya Molecular Nutrition & Food Research.2025;[Epub] CrossRef
Asprosin Levels in Adults with Type 2 Diabetes Mellitus and Diabetic Kidney Disease: A Systematic Review and Meta-Analysis Jovana Ristic, Sena Kodalak, Gonzalo Peralta-Jiménez, Maria Moura de Lima, Marijana Kovacevic, Srdjan Masic, Tatjana Nikolic Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 2493. CrossRef
Diabetic kidney disease: exploring mechanistic depths and the future of pharmacological intervention Pratik Shankar Rakshe, Anil Bhanudas Gaikwad Naunyn-Schmiedeberg's Archives of Pharmacology.2025;[Epub] CrossRef
Sirtuin 3 in diabetic kidney disease: mechanisms and pharmacotherapy Yinfeng Chen, Ying Wang, Dongrong Yu, Hailing Zhao, Ping Li Renal Failure.2025;[Epub] CrossRef
Mechanism of
Rhizoma Chuanxiong
for the treatment of diabetic kidney disease based on network pharmacology
Yuhe Yan, Honghong Shi, Yue Li, Xing Wan, Jinxin Li, Lihua Wang Renal Failure.2025;[Epub] CrossRef
The potential adding therapeutic effect of pentoxifylline and/or folic acid for chronic kidney disease patients: randomized controlled trial Amira Reda Muhammad Galal, Nahla Mohamed Teama, Karema Abu–Elfotuha, Ahmed D. Alatawi, Hanan Alshareef, Ahmed M. E. Hamdan, Ahmed Aljabri, Mohannad Alshibani, Zeinab AlKasaby Mahmoud Zalat BMC Nephrology.2025;[Epub] CrossRef
Association between a diabetes-predictive index and diabetes-related kidney disease in U.S. adults: A cross-sectional study Haonan Wu, Zheng Nan Preventive Medicine Reports.2025; 58: 103225. CrossRef
Asprosin Aggravates Tubular Epithelial Cell Injury and Phenotypic Transformation via Mitochondrial Dynamics Disorder Mediated by Excessive Drp1 SUMOylation in Diabetic Nephropathy Mice Qianqian Huang, Xiaowei Xiong, Sheng Chen, Yuan Wang, Li Wang, Wentao Liu, Chen Liu, Guohua Zeng, Qiren Huang Advanced Science.2025;[Epub] CrossRef
C3AR1 may aggravate diabetic nephropathy by mediating oxidative stress via ITGB2 regulation in renal tubular epithelial cells Alex Abura, Shan Gao, Shinsuke Yuasa PLOS One.2025; 20(9): e0331900. CrossRef
Exploration of the renoprotective effect of Yi-Shen-Hua-Shi granules on db/db mice and the mechanism of podocyte apoptosis based on the GRP78/CHOP signaling pathway Yanmo Cai, Yunhua Liu, Sitong Wang, Ge Jin, Kaidong Zhou, Xin Zhou, Xinxue Zhang, Min Zhang, Zongjiang Zhao Frontiers in Pharmacology.2025;[Epub] CrossRef
Protective effects of Shenkang injection against diabetic kidney disease via p38 MAPK/NFκB/MCP-1/CCR2 pathway inhibition Xin Zhou, Sitong Wang, Ge Jin, Kaidong Zhou, Yanmo Cai, Zongjiang Zhao Frontiers in Endocrinology.2025;[Epub] CrossRef
Prevalence of diabetes and prediabetes among working-age adults and influencing factors of new-onset diabetes: a five-year cohort study (2018–2023) Jing Tan, Mingzhu Chen, Yang Lei, Xiaofen Shi, Cuiping Cao, Naili Du, Yuyou Yao, Xiaojuan Yao Frontiers in Endocrinology.2025;[Epub] CrossRef
Celastrol, a bioactive compound from Tripterygium wilfordii, exerts renoprotective effects by modulating the gut-kidney axis and PPAR signaling in a mouse model of diabetic kidney disease Yue-Wen Tang, Jia-Wei Cao, Meng-Dan Lu, Ru-Chun Yang, Feng Wan Asian Pacific Journal of Tropical Biomedicine.2025; 15(9): 353. CrossRef
Expression Profile of Urinary Exosomal miRNAs in Patients With Diabetic Kidney Disease and Their Association With Kidney Damage Juan Li, Lulu Han, Ting Wang, Lin Yang, Hong Zhou, Pawel Grzmil International Journal of Endocrinology.2025;[Epub] CrossRef
Commentary on: Inhibition of LINC00707/miR‐223‐3p/FKBP5 axis has a protective effect on diabetic kidney disease Yirui Zhao, Fengyue Zhang Journal of Diabetes Investigation.2025; 16(12): 2251. CrossRef
Research on Glycemic Variability Characteristics in Diabetic Patients Undergoing Hemodialysis 俊杰 苏 Journal of Clinical Personalized Medicine.2025; 04(05): 100. CrossRef
Short-Term: Cellular Metabolism and Gene Expression During the Onset of Diabetic Kidney Disease: A Diabetes Mellitus Experimental Model Jéssica Encinas, Glaucia Veiga, Joyce Raimundo, Matheus Perez, Giuliana Petri, Renan Cavalheiro, Pedro Reis, Laura Maifrino, Beatriz Alves, Fernando Fonseca International Journal of Molecular Sciences.2025; 26(19): 9676. CrossRef
Construction of a diagnostic model and identification of effect genes for diabetic kidney disease with concurrent vascular calcification based on bioinformatics and multiple machine learning approaches Lili Huang, Wenjing Wu, Shenhui Lv, Danfang Deng, Xiaoqin Wang Frontiers in Molecular Biosciences.2025;[Epub] CrossRef
Selected miRNAs in Urinary Extracellular Vesicles Show Promise for Early and Specific Diagnostics of Diabetic Kidney Disease Karina Barreiro, Jenni Karttunen, Erkka Valo, Essi Viippola, Ileana Quintero, Annemari Käräjämäki, Antti Rannikko, Harry Holthöfer, Andrea Ganna, Niina Sandholm, Lena M. Thorn, Per‐Henrik Groop, Tiinamaija Tuomi, Om Prakash Dwivedi, Maija Puhka Journal of Extracellular Biology.2025;[Epub] CrossRef
Metabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the Warburg effect, ketones, and SGLT2 inhibitors Pedro Carrera-Bastos, Marcel H. A. Muskiet, Fernando Mata-Ordoñez, Leo Pruimboom, Alejandro Lucia, Raul M. Luque, Frits A. J. Muskiet Reviews in Endocrine and Metabolic Disorders.2025;[Epub] CrossRef
Multi-omics and machine learning identify FN1 and ALDH2 as diagnostic biomarkers and therapeutic targets in early and late diabetic kidney disease Jingwei Lin, Yingying Zheng, Diman Mai, Fuxiang Fang, Zhuokun Wei, Mengyu Liu, Trung Hieu Pham, Ming Li, Jiawen Zhao Renal Failure.2025;[Epub] CrossRef
Yiqi Wenyang Formula ameliorates diabetic kidney disease via inhibiting inflammation and regulating the gut microbiota-bile acid axis in mice by FXR signaling pathway Tongyi Yuan, Xiang Gao, Xinxin Wang, Xiaolei Tang, Zuguo Liang, Yifei Yin, Songyan Liu, Jianze Ou, Wenjie Su, Zepeng Zhang, Xiangyan Li, Qingxia Huang, Daqing Zhao, He Zhang Chinese Medicine.2025;[Epub] CrossRef
Qing-Re-Xiao-Zheng-yi-qi formula protects renal function by stabilizing lysosomal membranes and inhibiting NLRP3-inflammasome-mediated pyroptosis in diabetic kidney disease Lei Tian, Lin Wang, Yutong Wang, Weijing Liu, Wenjing Zhao, Yaoxian Wang Annals of Medicine.2025;[Epub] CrossRef
The Inflammatory Cell Death in Diabetic Kidney Disease: Integrating Multifactorial Mechanisms into Novel Therapeutics Bin Fang, Wei Huang, Sijia Du, Yu Hao, Fangfang He, Chun Zhang International Journal of Molecular Sciences.2025; 26(22): 11033. CrossRef
Rhein Inhibits Podocyte Ferroptosis and Epithelial-Mesenchymal Transition in Diabetic Nephropathy by Activating the SIRT1/p53/SLC7A11 Pathway Wei Hu, Dan Xiong BIOCELL.2025; 49(9): 1711. CrossRef
Diagnostic Roles of circXPNPEP3 as Biomarker for Diabetic Nephropathy Miao Liu, Qiunan Zhan, Junjun Zhu, Junli Zhao, Danyan Min Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 4287. CrossRef
Protective Effects of Hydrogen Treatment Against High Glucose-Induced Oxidative Stress and Apoptosis via Inhibition of the AGEs/RAGE/NF-κB Signaling Pathway in Skin Cells Pan Yu, Nan Hong, Qiong Wu, Zhipeng Zhao Endocrine, Metabolic & Immune Disorders - Drug Targets.2025;[Epub] CrossRef
The Clinical Significance of Serum Sirtuin 2 in Diabetic Nephropathy: Evidence for a Potential Biomarker of Renal Injury Ozgur Yilmaz, Osman Erinc, Murvet Algemi, Recep Demirci, Sengul Aydin Yoldemir, Murat Akarsu Journal of Clinical Medicine.2025; 14(22): 8095. CrossRef
The “Picasso faces” of diabetic kidney disease – how the art of phenotyping and molecular biomarkers is transforming clinical nephrology: an observational study in patients with type 2 diabetes Małgorzata Rodzoń-Norwicz, Natalia Potocka, Marzena Skrzypa, Izabela Zawlik, Katarzyna Milian–Ciesielska, Patryk Kogut, Krzysztof Gargasz, Michael Maes, Magdalena Sowa-Kućma, Agnieszka Gala-Błądzińska BMC Nephrology.2025;[Epub] CrossRef
Diabetic peripheral neuropathy as measured using a point‐of‐care sural nerve conduction device is associated with a faster decline in renal function in patients with type 2 diabetes Tatsuya Fukuda, Akiko Fujii, Taro Akihisa, Naoya Otsubo, Tetsuya Yamada, Chisato Maki Journal of Diabetes Investigation.2025;[Epub] CrossRef
The Association of Lipoic Acid Synthase (LIAS) Gene Methylation With Diabetic Kidney Disease Ziyi Feng, Ting Liu, Peng Gao, Yongwei Jiang, Meimei Zhao, Yi Liu, Haoyan Zhu, Mo Li, Nan Li, Xiaomu Kong, Liang Ma, Zhipeng Tao Journal of Diabetes Research.2025;[Epub] CrossRef
Association between triglyceride–glucose index and its derivatives and lung adenocarcinoma risk: a case–control study in Chinese adults Pengcheng Qiu, Jinshi Xie, Yayuan He, Rizheng Cong, Keyue Huang, Bo Huang Frontiers in Endocrinology.2025;[Epub] CrossRef
Klotho in diabetes mellitus: research progress and clinical implications Tingyuan Zhu, Songfeng Zhao, Ning Lu Frontiers in Endocrinology.2025;[Epub] CrossRef
The mediating role of inflammation in the association between coagulation parameters and diabetic kidney diseases in patients with type 2 diabetes mellitus: a muti-center cross-sectional retrospective study in Southwest China from 2013 to 2022 Bei-Hui Ren, Ling-Zhi Xing, Bai-Yu-Lu Chen, Guo-Jia Liao, Li-Yuan Chen, Ying-Dan Zhang, Jie Fan, Ling Chen BMC Nephrology.2025;[Epub] CrossRef
Role of polyphenols in the management of diabetic complications Jeevika Raina, Atika Firdous, Gurvinder Singh, Rajesh Kumar, Charanjit Kaur Phytomedicine.2024; 122: 155155. CrossRef
Single-Cell RNA Sequencing Reveals RAC1 Involvement in Macrophages Efferocytosis in Diabetic Kidney Disease Yi Song, Yifan Liu, Feng Guo, Lin Zhao, Guijun Qin Inflammation.2024; 47(2): 753. CrossRef
Role of MCP-1 as an inflammatory biomarker in nephropathy Yanlong Liu, Ke Xu, Yuhua Xiang, Boyan Ma, Hailong Li, Yuan Li, Yue Shi, Shuju Li, Yan Bai Frontiers in Immunology.2024;[Epub] CrossRef
Urinary podocyte stress marker as a prognostic indicator for diabetic kidney disease Lingfeng Zeng, Jack Kit-Chung Ng, Winston Wing-Shing Fung, Gordon Chun-Kau Chan, Kai-Ming Chow, Cheuk-Chun Szeto BMC Nephrology.2024;[Epub] CrossRef
Identification and validation of immune and cuproptosis - related genes for diabetic nephropathy by WGCNA and machine learning Yubing Chen, Lijuan Liao, Baoju Wang, Zhan Wu Frontiers in Immunology.2024;[Epub] CrossRef
Specific Alternation of Gut Microbiota and the Role of Ruminococcus gnavus in the Development of Diabetic Nephropathy Jinni Hong, Tingting Fu, Weizhen Liu, Yu Du, Junmin Bu, Guojian Wei, Miao Yu, Yanshan Lin, Cunyun Min, Datao Lin Journal of Microbiology and Biotechnology.2024; 34(3): 547. CrossRef
The triglyceride-glucose index is superior to homeostasis model assessment of insulin resistance in predicting metabolic syndrome in an adult population in the United States Beverley Adams-Huet, Rafael Zubirán, Alan T. Remaley, Ishwarlal Jialal Journal of Clinical Lipidology.2024; 18(4): e518. CrossRef
Association of the dietary inflammatory index with complicated diabetic kidney disease in people with diabetes mellitus: evidence from NHANES 2009–2018 Yixin Rui, Xiumeng Zhang, Hongxiao Xie, Hu Qi, Rong Liu, Nan Zeng Acta Diabetologica.2024; 61(11): 1375. CrossRef
Multiomics Analyses Identify AKR1A1 as a Biomarker for Diabetic Kidney Disease DengFeng Li, Fang-Chi Hsu, Nicholette D. Palmer, Liang Liu, Young A. Choi, Mariana Murea, John S. Parks, Donald W. Bowden, Barry I. Freedman, Lijun Ma Diabetes.2024; 73(7): 1188. CrossRef
Serum L C3-II levels in type 2 diabetic patients with impaired renal functions Shahab Ahmed Salıh Gezh, Koksal Deveci, Hakan Sivgin, Figen Guzelgul Cytokine.2024; 181: 156683. CrossRef
Diabetic Nephropathy as a Result of Uncontrolled Hyperglycemia Camila Silva de Aquino, Estênio Gabriel Miranda, Francisco José Pascoal Ribeiro Júnior, Hérika Juliana de Araújo Lucena, Jéssica Pará Amaral de Oliveira, João Ferreira Lima Neto, Lênio Airam de Pinho, Miguel Valentim Rodrigues, Pedro Henrique Borges Silve Revista de Gestão Social e Ambiental.2024; 18(1): e07716. CrossRef
Pharmacological effects of bioactive agents in earthworm extract: A comprehensive review Zihan Zhu, Xinyi Deng, Wenqing Xie, Hengzhen Li, Yusheng Li, Zhenhan Deng Animal Models and Experimental Medicine.2024; 7(5): 653. CrossRef
Efficacy and safety of polyethylene glycol loxenatide in treating mild-to-moderate diabetic kidney disease in type 2 diabetes patients: a randomized, open-label, clinical trial YongSheng Cao, Shujie Cao, Jiangang Zhao, Jianqin Zhao, Yanan Zhao, Ying Liu Frontiers in Endocrinology.2024;[Epub] CrossRef
Fish oil supplementation in relation to the risk of chronic kidney disease among patients with diabetes Yang Ao, Hao Ye, Xiaohui Liu, Yin Li, Haoyin Liu, Shu Ye, Yepeng Hu, Pan Zhuang, Yu Zhang, Chao Zheng, Jingjing Jiao Diabetes, Obesity and Metabolism.2024; 26(11): 5283. CrossRef
CYSTATIN C—A Monitoring Perspective of Chronic Kidney Disease in Patients with Diabetes Alexandra-Mihaela Visinescu, Emilia Rusu, Andrada Cosoreanu, Gabriela Radulian International Journal of Molecular Sciences.2024; 25(15): 8135. CrossRef
Role of proadrenomedullin in the progression of diabetic kidney disease in patients with type 2 diabetes mellitus A.M. Urbanovych, A.P. Vereshchynska INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2024; 20(4): 266. CrossRef
Sirt6 overexpression relieves ferroptosis and delays the progression of diabetic nephropathy via Nrf2/GPX4 pathway Lingyu Du, Canghui Guo, Shengnan Zeng, Ke Yu, Maodong Liu, Ying Li Renal Failure.2024;[Epub] CrossRef
Single-cell RNA sequencing in diabetic kidney disease: a literature review Wei Tan, Jiaoyan Chen, Yunyan Wang, Kui Xiang, Xianqiong Lu, Qiuyu Han, Mingyue Hou, Jurong Yang Renal Failure.2024;[Epub] CrossRef
Podocyte Death in Diabetic Kidney Disease: Potential Molecular Mechanisms and Therapeutic Targets Suye Zhong, Na Wang, Chun Zhang International Journal of Molecular Sciences.2024; 25(16): 9035. CrossRef
Serum biomarkers for predicting microvascular complications of diabetes mellitus Jiajia Wang, Xiaoyi Song, Ziqiao Xia, Shu Feng, Hangfeng Zhang, Chengjie Xu, Hui Zhang Expert Review of Molecular Diagnostics.2024; 24(8): 703. CrossRef
Association of Serum Tsukushi Levels with Urinary Albumin-Creatinine Ratio in Type 2 Diabetes Patients Yanyan Li, Xia Deng, Xunan Wu, Ligang Zhou, Guoyue Yuan Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 3295. CrossRef
Liraglutide ameliorates inflammation and fibrosis by downregulating the TLR4/MyD88/NF-κB pathway in diabetic kidney disease Linjing Huang, Tingting Lin, Meizhen Shi, Peiwen Wu American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.2024; 327(4): R410. CrossRef
Molecular Therapeutics for Diabetic Kidney Disease: An Update Man Guo, Fangfang He, Chun Zhang International Journal of Molecular Sciences.2024; 25(18): 10051. CrossRef
Angiopoietin‐like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients Yan Wang, Kun Li, Shasha Yuan, Caiguo Yu, Ruili Yin, Di Wang, Yongsong Xu, Lijie Zhang, Lingling Wei, Yanan Cheng, Lin Mao, Dong Zhao, Longyan Yang Journal of Diabetes Investigation.2024; 15(12): 1763. CrossRef
Integrating network pharmacology and experimental validation to decipher the pharmacological mechanism of DXXK in treating diabetic kidney injury Chenxu Zhang, Zhangxin Ji, Na Xu, Jingjing Yuan, Wen Zeng, Yadong Wang, Qing He, Jiaxing Dong, Xinyu Zhang, Dongmei Yang, Wei Jiang, Yibo Yan, Wencui Shang, Jun Chu, Quangen Chu Scientific Reports.2024;[Epub] CrossRef
Update on the Pathogenesis, Diagnosis, and Treatment of Diabetic Tubulopathy Danfeng Liu, Xiaojie Chen, Weiting He, Min Lu, Qiuling Li, Shaogui Zhang, Jianteng Xie, Yifan Zhang, Wenjian Wang Integrative Medicine in Nephrology and Andrology.2024;[Epub] CrossRef
Identification of circulating microbial DNA and its association with kidney function in patients with diabetic kidney disease Hoang Thuy Linh, Megumi Oshima, Keisuke Sako, Masahiro Konishi, Daiki Hayashi, Hajime Sanada, Takahiro Yuasa, Akihiko Koshino, Keisuke Horikoshi, Taichiro Minami, Shunsuke Tsuge, Akira Tamai, Shiori Nakagawa, Ryo Nishioka, Takeshi Zoshima, Kiyoaki Ito, Ic Nephrology.2024; 29(12): 909. CrossRef
Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus Inha Jung, Seungyoon Nam, Da Young Lee, So Young Park, Ji Hee Yu, Ji A Seo, Dae Ho Lee, Nan Hee Kim Diabetes & Metabolism Journal.2024; 48(6): 1126. CrossRef
Role of Epigenetic Changes in the Pathophysiology of Diabetic Kidney Disease Marita Liebisch, Gunter Wolf Glomerular Diseases.2024; 4(1): 211. CrossRef
Characteristics and Risk of Incident Diabetic Nephropathy between Early-onset versus Late-onset Type 2 Diabetics of Nigerian Origin Collins Amadi, Johnbosco Chidozie Okafor, Ochuko Otokunefor, Ezra Agbo European Journal of Medical and Health Sciences.2024; 6(6): 60. CrossRef
Research progress of gut microbiome and diabetic nephropathy Chenling Chu, Tapas Ranjan Behera, Ying Huang, Wenhui Qiu, Jiayi Chen, Quanquan Shen Frontiers in Medicine.2024;[Epub] CrossRef
Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy Fengzhao Liu, Zhenyu Yang, Jixin Li, Tao Wu, Xiangyu Li, Lijuan Zhao, Wenru Wang, Wenfei Yu, Guangheng Zhang, Yunsheng Xu Molecular Medicine.2024;[Epub] CrossRef
Dynamic changes of inflammatory markers in the early stages of chronic kidney disease in patients with type 1 diabetes mellitus MV Osikov, LA Efros, LYu Zhuravleva, AA Fedosov Bulletin of Russian State Medical University.2024;[Epub] CrossRef
A Narrative Review of New Treatment Options for Diabetic Nephropathy Aadhira Pillai, Darshna Fulmali Cureus.2023;[Epub] CrossRef
Bamboo leaf: A review of traditional medicinal property, phytochemistry, pharmacology, and purification technology Yaqian Cheng, Siqi Wan, Linna Yao, Ding Lin, Tong Wu, Yongjian Chen, Ailian Zhang, Chenfei Lu Journal of Ethnopharmacology.2023; 306: 116166. CrossRef
Molecular Pathways of Diabetic Kidney Disease Inferred from Proteomics Lan Wei, Yuanyuan Han, Chao Tu Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 117. CrossRef
Omics and Artificial Intelligence in Kidney Diseases Nadja Grobe, Josef Scheiber, Hanjie Zhang, Christian Garbe, Xiaoling Wang Advances in Kidney Disease and Health.2023; 30(1): 47. CrossRef
Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective Soumik Das, Ramanathan Gnanasambandan Life Sciences.2023; 316: 121414. CrossRef
Pediatric Diabetic Nephropathy: Novel Insights from microRNAs Francesca Lanzaro, Annalisa Barlabà, Angelica De Nigris, Federica Di Domenico, Valentina Verde, Emanuele Miraglia del Giudice, Anna Di Sessa Journal of Clinical Medicine.2023; 12(4): 1447. CrossRef
Novel Biomarkers of Diabetic Kidney Disease Jorge Rico-Fontalvo, Gustavo Aroca-Martínez, Rodrigo Daza-Arnedo, José Cabrales, Tomás Rodríguez-Yanez, María Cardona-Blanco, Juan Montejo-Hernández, Dairo Rodelo Barrios, Jhonny Patiño-Patiño, Elber Osorio Rodríguez Biomolecules.2023; 13(4): 633. CrossRef
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies Yiwen Li, Yanfei Liu, Shiwei Liu, Mengqi Gao, Wenting Wang, Keji Chen, Luqi Huang, Yue Liu Signal Transduction and Targeted Therapy.2023;[Epub] CrossRef
Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes Lijun Zhao, Yutong Zou, Yucheng Wu, Linli Cai, Yuancheng Zhao, Yiting Wang, Xiang Xiao, Qing Yang, Jia Yang, Honghong Ren, Nanwei Tong, Fang Liu Frontiers in Endocrinology.2023;[Epub] CrossRef
Identification of a New RNA and Protein Integrated Biomarker Panel Associated with Kidney Function Impairment in DKD: Translational Implications Alessandra Scamporrino, Stefania Di Mauro, Agnese Filippello, Grazia Di Marco, Antonino Di Pino, Roberto Scicali, Maurizio Di Marco, Emanuele Martorana, Roberta Malaguarnera, Francesco Purrello, Salvatore Piro International Journal of Molecular Sciences.2023; 24(11): 9412. CrossRef
Increased serum PCSK9 levels are associated with renal function impairment in patients with type 2 diabetes mellitus Zhicai Feng, Xiangyu Liao, Hao Zhang, Juan Peng, Zhijun Huang, Bin Yi Renal Failure.2023;[Epub] CrossRef
Analysis of Serum Pyrodeath Re-lated Proteins and Renal Injury in Patients with Type 2 DKD 茹洁 马 Asian Case Reports in Emergency Medicine.2023; 11(02): 53. CrossRef
Loganin reduces diabetic kidney injury by inhibiting the activation of NLRP3 inflammasome-mediated pyroptosis Xiangri Kong, Yunyun Zhao, Xingye Wang, Yongjiang Yu, Ying Meng, Guanchi Yan, Miao Yu, Lihong Jiang, Wu Song, Bingmei Wang, Xiuge Wang Chemico-Biological Interactions.2023; 382: 110640. CrossRef
Machine-learning algorithm-based prediction of a diagnostic model based on oxidative stress-related genes involved in immune infiltration in diabetic nephropathy patients Heng-Mei Zhu, Na Liu, Dong-Xuan Sun, Liang Luo Frontiers in Immunology.2023;[Epub] CrossRef
The roles of gut microbiota and its metabolites in diabetic nephropathy Hui Zhao, Cheng-E Yang, Tian Liu, Ming-Xia Zhang, Yan Niu, Ming Wang, Jun Yu Frontiers in Microbiology.2023;[Epub] CrossRef
High triglyceride levels increase the risk of diabetic microvascular complications: a cross-sectional study Jiahang Li, Lei Shi, Guohong Zhao, Fei Sun, Zhenxing Nie, Zhongli Ge, Bin Gao, Yan Yang Lipids in Health and Disease.2023;[Epub] CrossRef
Correlation of Kidney Injury Molecule-1 and Nephrin Levels in Iraqi Patients with Diabetic Nephropathy Raghda Hisham Aljorani, Eman Saadi Saleh , Khalaf Gata Hussein Al Mohammadawi Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ).2023; 5: 99. CrossRef
Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies Marina Darenskaya, Sergey Kolesnikov, Natalya Semenova, Lyubov Kolesnikova International Journal of Molecular Sciences.2023; 24(15): 12378. CrossRef
Evaluation of Neutrophil/Lymphocyte Ratio, Low-Density Lipoprotein/Albumin Ratio, and Red Cell Distribution Width/Albumin Ratio in the Estimation of Proteinuria in Uncontrolled Diabetic Patients Duygu Tutan, Murat Doğan Cureus.2023;[Epub] CrossRef
Hedysarum polybotrys polysaccharide attenuates renal inflammatory infiltration and fibrosis in diabetic mice by inhibiting the HMGB1/RAGE/TLR4 pathway Changqing Xu, Yanxu Cheng, Zongmei Liu, Xiaoyan Fu Experimental and Therapeutic Medicine.2023;[Epub] CrossRef
Inhibition of MD2 by natural product-drived JM-9 attenuates renal inflammation and diabetic nephropathy in mice Minxiu Wang, Qianhui Zhang, Shuaijie Lou, Leiming Jin, Gaojun Wu, Wenqi Wu, Qidong Tang, Yi Wang, Xiaohong Long, Ping Huang, Wu Luo, Guang Liang Biomedicine & Pharmacotherapy.2023; 168: 115660. CrossRef
Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes Pasquale Esposito, Daniela Picciotto, Francesca Cappadona, Francesca Costigliolo, Elisa Russo, Lucia Macciò, Francesca Viazzi World Journal of Diabetes.2023; 14(10): 1450. CrossRef
Mitochondrial antiviral signaling protein: a potential therapeutic target in renal disease Meng Wu, Zhiyin Pei, Guangfeng Long, Hongbing Chen, Zhanjun Jia, Weiwei Xia Frontiers in Immunology.2023;[Epub] CrossRef
Research progress on multiple cell death pathways of podocytes in diabetic kidney disease Can Yang, Zhen Zhang, Jieting Liu, Peijian Chen, Jialing Li, Haiying Shu, Yanhui Chu, Luxin Li Molecular Medicine.2023;[Epub] CrossRef
Quantitative profiling of carboxylic compounds by gas chromatography-mass spectrometry for revealing biomarkers of diabetic kidney disease Rongrong Zhu, Yan Yuan, Rourou Qi, Jianying Liang, Yan Shi, Hongbo Weng Journal of Chromatography B.2023; 1231: 123930. CrossRef
Jiangtang Decoction Ameliorates Diabetic Kidney Disease Through the Modulation of the Gut Microbiota Jinni Hong, Tingting Fu, Weizhen Liu, Yu Du, Junmin Bu, Guojian Wei, Miao Yu, Yanshan Lin, Cunyun Min, Datao Lin Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 3707. CrossRef
GLP-1RA Combined with SGLT2 Inhibitors for the Treatment of Diabetic Kidney Disease: A Meta Analysis 莹 郭 Advances in Clinical Medicine.2023; 13(11): 18117. CrossRef
Potential application of Klotho as a prognostic biomarker for patients with diabetic kidney disease: a meta-analysis of clinical studies Li Xia Yu, Min Yue Sha, Yue Chen, Fang Tan, Xi Liu, Shasha Li, Qi-Feng Liu Therapeutic Advances in Chronic Disease.2023;[Epub] CrossRef
Research progress of natural active compounds on improving podocyte function to reduce proteinuria in diabetic kidney disease Le Gong, Rui Wang, Xinyu Wang, Jing Liu, Zhaodi Han, Qian Li, Yi Jin, Hui Liao Renal Failure.2023;[Epub] CrossRef
Identification of potential crosstalk genes and mechanisms between periodontitis and diabetic nephropathy through bioinformatic analysis Huijuan Lu, Jia Sun, Jieqiong Sun Medicine.2023; 102(52): e36802. CrossRef
Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease Stefania Di Mauro, Alessandra Scamporrino, Agnese Filippello, Maurizio Di Marco, Maria Teresa Di Martino, Francesca Scionti, Antonino Di Pino, Roberto Scicali, Roberta Malaguarnera, Francesco Purrello, Salvatore Piro International Journal of Molecular Sciences.2022; 23(15): 8198. CrossRef
Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics Nam Hoon Kim, Nan Hee Kim Diabetes & Metabolism Journal.2022; 46(4): 543. CrossRef
Partial Synthetic PPARƳ Derivative Ameliorates Aorta Injury in Experimental Diabetic Rats Mediated by Activation of miR-126-5p Pi3k/AKT/PDK 1/mTOR Expression Yasmin M. Ahmed, Raha Orfali, Nada S. Abdelwahab, Hossam M. Hassan, Mostafa E. Rateb, Asmaa M. AboulMagd Pharmaceuticals.2022; 15(10): 1175. CrossRef
Polydatin attenuates tubulointerstitial fibrosis in diabetic kidney disease by inhibiting YAP expression and nuclear translocation Manlin He, Lan Feng, Yang Chen, Bin Gao, Yiwei Du, Lu Zhou, Fei Li, Hongbao Liu Frontiers in Physiology.2022;[Epub] CrossRef
Prevalence of diabetic nephropathy in the diabetes mellitus population: A protocol for systematic review and meta-analysis Sicheng Li, Huidi Xie, Yang Shi, Hongfang Liu Medicine.2022; 101(42): e31232. CrossRef
Stratification of diabetic kidney diseases via data-independent acquisition proteomics–based analysis of human kidney tissue specimens Qinghua Huang, Xianming Fei, Zhaoxian Zhong, Jieru Zhou, Jianguang Gong, Yuan Chen, Yiwen Li, Xiaohong Wu Frontiers in Endocrinology.2022;[Epub] CrossRef
Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives Ziyan Xie, Xinhua Xiao Frontiers in Endocrinology.2022;[Epub] CrossRef
Diabetic Kidney Disease Susanne B. Nicholas, Amy K. Mottl Nephrology Self-Assessment Program.2022; 21(5): 394. CrossRef